多民族亚洲人群中系统性硬化症的工作生产力与经济负担
该研究评估了111例系统性硬化症(SSc)患者的工作生产力损失、失业相关因素及经济负担。患者平均病程9.1年,29.7%失业,失业者平均失业年龄44.2岁,相当于损失22.8年就业年限;就业患者中53.4%报告工作生产力损失,占工作周的45.9%。高脂血症与工作生产力损失和活动障碍相关,失业和工作生产力损失的年人均成本分别为53,244和13,045新加坡元。
要点
- SSc患者失业率29.7%,失业者平均损失22.8年就业年限。
- 就业患者中53.4%存在工作生产力损失,占工作周45.9%。
- 高脂血症与工作生产力损失和活动障碍独立相关。
核心结论
- SSc导致显著的失业和工作生产力损失,对患者和社会造成沉重经济负担。
- 识别与失业和工作生产力损失相关的因素可能有助于减轻SSc负担。
研究设计与样本
- 研究纳入111例多民族亚洲SSc患者,平均病程9.1年,收集就业状态和工作生产力损失数据。
- 采用逻辑回归和线性回归分析人口学及疾病特征与失业、工作生产力损失和活动障碍的关联。
- 采用人力资本法估算失业和工作生产力损失的成本。
主要发现
- 111例患者中33例(29.7%)失业,失业者平均年龄44.2岁,相当于损失22.8年就业年限。
- 多变量分析中未发现人口学或疾病特征与失业状态显著相关。
- 73例就业患者中39例(53.4%)报告工作生产力损失,占工作周的45.9%。
- 多变量分析中高脂血症与工作生产力损失相关(系数-19.01,P=0.03)。
- 78例就业患者中37例(47.4%)和33例失业患者中19例(57.6%)报告活动障碍,分别占前一周的42.2%和50.0%;高脂血症与活动障碍相关(系数-18.56,P<0.01)。
关键数值与推荐
- 失业和工作生产力损失的年人均成本分别为53,244和13,045新加坡元。
临床怎么用
- 临床应关注SSc患者的工作生产力损失和活动障碍,尤其合并高脂血症者。
- 可将失业和工作生产力损失纳入SSc综合管理评估,以减轻疾病经济负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess work productivity, identify associated factors and evaluate the economic burden of systemic sclerosis (SSc) in a multiethnic Asian population. METHODS: Data on employment status and work productivity loss were collected. Associations between demographic and disease characteristics and unemployment status, work productivity loss, and activity impairment were examined using logistic and linear regression analyses, as appropriate. Costs of unemployment and work productivity loss were estimated using the human capital approach. RESULTS: Of 111 patients with a mean disease duration of 9.1 years, 33 (29.7%) were unemployed. Their mean age at unemployment was 44.2 years, equating to 22.8 years of lost employment. No demographic and disease characteristics were significantly associated with unemployment status in multivariable analysis. Of 73 employed patients, 39 (53.4%) reported work productivity loss, accounting for 45.9% of the working week. The presence of hyperlipidemia (coefficient -19.01, P = 0.03) was associated with work productivity loss in multivariable analysis. In total, 37 of 78 employed patients (47.4%) and 19 of 33 unemployed patients (57.6%) reported activity impairment, accounting for 42.2% and 50.0%, respectively, of the preceding week. The presence of hyperlipidemia (coefficient -18.56, P < 0.01) was associated with activity impairment in multivariable analysis. Annual cost of unemployment and work productivity loss were estimated to be $53,244 and $13,045 (Singapore dollar) per patient, respectively. CONCLUSION: SSc imposes significant unemployment and work productivity loss and causes a substantial economic burden to both affected individuals and society. Modifying the identified factors associated with unemployment and work productivity loss may reduce the burden of SSc.
引用
- Xiang L, Kua SMY, Low AHL, et al. Work Productivity and Economic Burden of Systemic Sclerosis in a Multiethnic Asian Population. Arthritis Care Res (Hoboken). 2022. PMID: 33253494. doi:10.1002/acr.24521
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。